BS
EW icon

Banco Santander’s Edwards Lifesciences EW Stock Holding History

Banco Santander’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$355K Sell
3,922
-467
-11% -$39.1K ﹤0.01% 426
2026
Q1 		$351K Hold
4,389
– – ﹤0.01% 397
2025
Q4 		$374K Buy
4,389
+415
+10% +$34.1K ﹤0.01% 383
2025
Q3 		$309K Buy
+3,974
New +$311K ﹤0.01% 410
2024
Q4 		– Sell
-24,274
Closed -$1.6M – 469
2024
Q3 		$1.6M Sell
24,274
-502
-2% -$36.5K 0.02% 244
2024
Q2 		$2.29M Sell
24,776
-739
-3% -$65.4K 0.03% 224
2024
Q1 		$2.44M Sell
25,515
-71,729
-74% -$6.03M 0.03% 223
2023
Q4 		$7.41M Buy
97,244
+1,911
+2% +$133K 0.09% 139
2023
Q3 		$6.6M Buy
95,333
+9,481
+11% +$762K 0.09% 139
2023
Q2 		$8.1M Buy
85,852
+112
+0.1% +$9.73K 0.11% 119
2023
Q1 		$7.09M Buy
85,740
+11,338
+15% +$891K 0.1% 103
2022
Q4 		$5.55M Buy
74,402
+4,588
+7% +$354K 0.08% 121
2022
Q3 		$5.77M Hold
69,814
– – 0.08% 127
2022
Q2 		$6.64M Buy
+69,814
New +$7.23M 0.09% 121
2021
Q4 		– Sell
-2,319
Closed -$263K – 427
2021
Q3 		$263K Buy
+2,319
New +$265K ﹤0.01% 386
2021
Q2 		– Sell
-3,251
Closed -$272K – 405
2021
Q1 		$272K Sell
3,251
-2,502
-43% -$212K ﹤0.01% 365
2020
Q4 		$525K Sell
5,753
-5,735
-50% -$476K ﹤0.01% 308
2020
Q3 		$917K Sell
11,488
-2,819
-20% -$220K 0.01% 236
2020
Q2 		$989K Buy
14,307
+1,791
+14% +$127K 0.01% 221
2020
Q1 		$787K Buy
12,516
+1,824
+17% +$132K 0.01% 265
2019
Q4 		$831K Buy
+10,692
New +$835K 0.01% 280
2018
Q4 		– Sell
-3,945
Closed -$229K – 359
2018
Q3 		$229K Sell
3,945
-403,806
-99% -$19.7M ﹤0.01% 343
2018
Q2 		$19.8M Buy
407,751
+402,756
+8,063% +$18.8M 0.23% 63
2018
Q1 		$232K Sell
4,995
-160,278
-97% -$6.96M ﹤0.01% 373
2017
Q4 		$6.21M Buy
165,273
+117,273
+244% +$4.3M 0.09% 88
2017
Q3 		$1.75M Hold
48,000
– – 0.03% 127
2017
Q2 		$1.89M Buy
+48,000
New +$1.75M 0.04% 97

Other funds holding EW

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
WT
Wellcome Trust London, United Kingdom $9.01B AUM 12.05% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $114B AUM 41.71% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Nordea Investment Management
Nordea Investment Management Stockholm, Sweden $123B AUM 38.85% 1-Year Est. Return
Universal-Beteiligungs- und Servicegesellschaft
Universal-Beteiligungs- und Servicegesellschaft Frankfurt Am Main, Germany $65.4B AUM 39.83% 1-Year Est. Return

Banco Santander's EW Position: Q2 2026 in Review

Banco Santander reduced its Edwards Lifesciences (EW) stake by 11% in Q2 2026, selling an estimated $39.1K and leaving 3,922 shares worth $355K. The position accounts for ﹤0.01% of the portfolio, ranked #426.

Banco Santander first reported a position in EW in Q2 2017 and has held it in 27 quarters since. The position peaked at $19.8M in Q2 2018. 774 funds tracked by Wall St. Rank hold EW as of Q2 2026.

  • Banco Santander held 3,922 shares of Edwards Lifesciences worth $355K as of Q2 2026.
  • Banco Santander sold 467 Edwards Lifesciences shares in Q2 2026, an estimated $39.1K.
  • Edwards Lifesciences made up ﹤0.01% of Banco Santander's portfolio in Q2 2026, its #426 holding.
  • Banco Santander first reported a position in Edwards Lifesciences in Q2 2017 and has held it in 27 quarters since.
  • Banco Santander's Edwards Lifesciences position peaked at $19.8M in Q2 2018.
  • 774 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2026.

Based on Banco Santander's 13F filing for Q2 2026, filed 29 Jul 2026.